The impact of user fees on health service utilization in low- and middle-income countries: how strong is the evidence?
Mylene Lagarde, Natasha Palmer
Volume 86, Number 11, November 2008, 839-848
Table 2. Quality assessment criteria applied to studies included in review of the effects of user fees on health service utilization in low- and middle-income countries
| C-RCTs | Random allocation is clearly described (unit and process). |
| Outcomes are measured at baseline. | |
| Outcome measures/data are reliable. | |
| There is no risk of exclusion bias. | |
| There is no risk of detection bias. | |
| There is no risk of contamination. | |
| The sampling strategy takes clusters into account (for C-RCTs).a | |
| Appropriate statistical analysis is (well) performed.a | |
| CBA studies | Control and intervention sites are comparable. |
| Outcome measures/data are reliable. | |
| There is no difference in outcomes between control and intervention sites at baseline. | |
| There is no exclusion or selection bias. | |
| There is no risk of contamination. | |
| Appropriate statistical analysis is (well) performed.a | |
| ITS studies | There is no risk that concurrent changes/events might have affected outcomes. |
| There is no risk of selection bias. | |
| There is no risk of detection bias. | |
| Outcome measures/data are reliable. | |
| Time of the intervention is clearly defined. | |
| Appropriate statistical analysis (ARIMA model or time series regression) is performed. | |
| Rationale for the number of points in the series collected is stated (and sufficient to control for the effects of potential seasonal variations in outcomes before and after).a | |
| Overall quality assessment | There is a low risk of bias: all criteria are clearly met. |
| There is a moderate risk of bias: one or two criteria are not clear or not met. | |
| There is a high risk of bias: more than two criteria are not clear or not met. | |
ARIMA, auto-regressive integrated moving average; CBA, controlled “before and after”; C-RCTs, cluster randomized controlled trials; ITS, interrupted time series.a Criterion added by the authors to the list of those suggested by the Cochrane Collaboration’s Effective Practice and Organisation of Care group.
